Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ARDELYX, INC. (ARDX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ARDELYX, INC. (ARDX), most recent 12 months reported: revenue $450.89M, net loss $55.7M, free cash flow -$17.92M. Latest balance sheet on file: liquid cash $281.83M, total debt $251.82M, net cash $30.01M. From SEC filings. Others in Pharmaceutical Preparations: ARCUTIS BIOTHERAPEUTICS, INC. · CORMEDIX INC. · ORGANOGENESIS HOLDINGS INC. · LIQUIDIA CORPORATION · ZAI LAB LIMITED · INNOVIVA, INC. · MANNKIND CORP · IRONWOOD PHARMACEUTICALS, INC.

Stock screener

Watchlist